| The role of OATP1B1 and OATP1B3 transporter polymorphisms in drug disposition and response to anticancer drugs: a review of the recent literature N Anabtawi, T Drabison, S Hu, A Sparreboom, Z Talebi Expert Opinion on Drug Metabolism & Toxicology 18 (7-8), 459-468, 2022 | 14 | 2022 |
| Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy Y Li, T Drabison, M Nepal, RH Ho, AF Leblanc, AA Gibson, Y Jin, W Yang, ... JCI insight 8 (14), 2023 | 8 | 2023 |
| Darolutamide does not interfere with OATP‐mediated uptake of docetaxel SAJ Buck, Z Talebi, T Drabison, Y Jin, AA Gibson, P Hu, P de Bruijn, ... International Journal of Cancer, 2024 | 3 | 2024 |
| Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 Mice Y Li, Y Kazuki, T Drabison, K Kobayashi, K Fujita, Y Xu, Y Jin, E Ahmed, ... Drug Metabolism and Disposition 52 (2), 80-85, 2024 | 1 | 2024 |
| Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen T Drabison, M Boeckman, Y Yang, KM Huang, P de Bruijn, MR Nepal, ... Cancer research communications 4 (9), 2489-2497, 2024 | | 2024 |
| Pharmacokinetic assessment of low dose decitabine in combination therapies: Development and validation of a sensitive uhplc-ms/ms method for murine plasma analysis N Anabtawi, T Drabison, Y Jin, ED Eisenmann, A Sparreboom, ... Journal of Chromatography B, 124209, 2024 | | 2024 |
| Strain-and Route-Dependent Plasma Pharmacokinetics and DRG Accumulation of Paclitaxel T Drabison, Y Xu, E Ahmed, S Kandalai, K Hoyt, K Obrietan, S Hu, ... The Journal of Pharmacology and Experimental Therapeutics 389, 259, 2024 | | 2024 |
| Identification of Pazopanib as an OATP1B1 Substrate from a Competitive Counterflow Screen T Drabison, M Boeckman, E Eisenmann, SD Baker, S Hu, A Sparreboom, ... The Journal of Pharmacology and Experimental Therapeutics 385, 174, 2023 | | 2023 |
| Contribution of CNT1 and CNT3 to the intestinal transport and pharmacokinetics of decitabine N Anabtawi, T Drabison, M Boeckman, Y Jin, M Halpin, AA Gibson, ... The Journal of Pharmacology and Experimental Therapeutics 385, 385, 2023 | | 2023 |
| Arylimidamides for use in treatment of cancers J ANTWI, J Byrd, K Werbovetz, P Sharma, S ELGAMAL, K LARKIN, ... | | 2023 |
